Form 4: Eli Lilly SVP Donald Zakrowski Sells 1,000 Shares Under 10b5-1 Plan
SEC Form 4 Filing
Donald Zakrowski, SVP of Finance & CAO at Eli Lilly & Co, sold 1,000 shares of common stock at $818.24 per share on March 13, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- On March 13, 2025, Donald A. Zakrowski, SVP, Finance, & CAO of Eli Lilly & Co, sold 1,000 shares of Eli Lilly common stock.
- The sale was executed at a price of $818.24 per share.
- Following the transaction, Zakrowski directly owns 5,839.659 shares of common stock.
- Zakrowski also indirectly owns 1,720.21 shares through a 401(k) plan.
- The transaction was conducted under a Rule 10b5-1 trading plan adopted on November 20, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an insider stock sale. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
This is a routine disclosure of an insider stock sale. It's common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The sale itself is unlikely to have a significant impact on the company's stock price.
Key Dates
| Date | Description |
|---|---|
| 11/20/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 03/13/2025 | Date of transaction (stock sale) |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.